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Results: Indications for PVR were valvular regurgitation (n=6), obstruction (n=3), and
both (n=1). Valve types were St. Jude (n=7), Starr-Edwards (n=2), and Bjork-Shiley
(n=1). In 5 pts, the mechanical PVR was placed within a conduit. Concomitant mechani-
cal tricuspid valve replacement (St. Jude) was performed in 6 pts. Postoperatively, all but
1 were anticoagulated with warfarin. During late follow-up (8.3 +/- 7.7 yrs, max 25 yrs), 1
pt required repeat PVR for outgrowth of prosthesis 25 yrs postoperatively, and 1 pt with
normal prosthetic pulmonary valve function underwent heart transplantation for severe
biventricular failure 3.5 yrs postoperatively. The average mean gradient across the
mechanical PVR by echocardiography in the remaining 8 pts was 11 +/- 7 mmHg. There
were no perivalvular leaks or vegetations, and no evidence of pannus formation or pros-
thesis dysfunction. There were 3 late minor bleeding events (epistaxis in 2 pts and men-
orrhagia in 1). There was 1 sudden late death 15 yrs after PVR, and 1 death from
unknown causes in the aforementioned pt with outgrowth of the mechanical PVR, 5.5 yrs
post re-PVR with a bioprosthesis. There were no cases of pulmonary emboli or PVR
thrombosis.
Conclusions: Mechanical PVR appears to provide excellent durability and hemodynamic
results without mechanical valve failure or valve thrombosis in this small series. Mechan-
ical prostheses should be considered for PVR in selected pts, particularly those who
require chronic warfarin anticoagulation for other reasons.
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840-6 Coarctation Long-Term Assessment (COALA-Study) 
Incidence of Restenosis and Hypertension After 
Surgical Repair
Alfred Hager, Simone Kanz, Harald Kaemmerer, Christian Schreiber, John Hess, 
Deutsches Herzzentrim München, TUM, München, Germany
Background: to assess the incidence of restenosis and arterial hypertension in patients
after surgical repair of aortic coarctation in a cross sectional study.
Patients and Methods: From 1974 to now 405 patients born before 1.1.1965 underwent
surgery for isolated aortic coarctation in our hospital. From those 383 who are still alive
26 moved to remote or unknown areas and 83 denied a follow up examination at our
institution. The study group of the remaining 274 patients (16 - 73 years old, 90 female,
184 male, 72% of those that are still alive), 18.4 ± 5.9 years (range 1 - 27 years) after sur-
gery, underwent a structured clinical investigation with a Doppler sonographic measure-
ment of the blood pressure at all limbs, exercise test, and ambulatory blood pressure
measurement.
Results: 29 patients (11%) already underwent surgery for restenosis, another 20 patients
(7%) had a leg-arm gradient of more than 20 mmHg suggesting restenosis now. Risk fac-
tors were young age at the first repair and first repair without end-to-end anastomosis.
67 Patients (24%) were already on antihypertensive drug therapy, another 48 patients
(18%) had a mean systolic blood pressure of 134 mmHg or higher in ambulatory blood
pressure measurement and should therefore also be classified hypertensive. Further-
more, another 28 patients (10%) showed a blood pressure during exercise exceeding 2
SD of reference values. All in all, only 131 patients (48%) had a normal blood pressure
reaction. The only independent risk factors for an abnormal blood pressure was a repair
without end-to-end anastomosis. Other risk factors like age at repair, age at investigation,
and body weight at investigation were not significant in a multiple regression analysis
anymore.
Conclusions: In the long-term follow up 18% of patients after surgery for aortic coarcta-
tion show restenosis. An arterial hypertensive blood pressure reaction is much more
common in long term follow up with an incidence of 52%. In only few patients hyperten-
sion is due to restenosis. Best results were achieved in patients in whom an end-to-end
anastomosis could be performed and in whom repair was not performed at a very young
age.
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1152-199 Thromboembolic Events Among Children With 
Cardiomyopathy: Results From the National Australian 
Childhood Cardiomyopathy Study
Robert G. Weintraub, Patty Chondros, Alan Nugent, John Carlin, Piers E.F Daubeney, 
National Australian Childhood Cardiomyopathy Study, Melbourne, Australia
Background: Subjects with cardiomyopathy (CM) are at risk from thromboembolism.
There is little information about predisposing factors and the magnitude of the risk in chil-
dren.
Methods: The National Australian Childhood Cardiomyopathy Study is a population-
based study, including all children in Australia with primary CM who presented at 0-10
years of age. Cases were classified according to WHO criteria. A thromboembolic event
was defined as the finding of intracardiac thrombus, or onset of organ dysfunction related
to an embolic event. Risk factors examined included CM type, congestive heart failure
(CHF) at diagnosis, duration of inotropic therapy, mechanical ventilation, ICU and hospi-
tal stay at presentation. Children not surviving 24 hours from presentation were excluded
from survival analysis. Study end-points were death or transplantation.
Results: There were 314 patients diagnosed with CM during the study period, of which
299 were included in survival analysis. Of these, 19 (6.4%) of these developed throm-
boembolic complications, including 14/172 (8.1%) with dilated CM, 3/39 (7.7%) with
unclassified CM, 1/12 (8.5%) with restrictive CM and 1/80 (1.2%) with hypertrophic CM
(p=0.02 compared to other cases). 6 of 19 (31.6%) of thromboembolic events occurred
<2 days of presentation and 14 (73.7%) occurred <30 days. CHF at presentation was
related to risk of thromboembolism (hazard ratio 5.0; 95% CI: 1.6-21.8). The one and 5-
year survival free from thromboembolic events were 93% (95% CI: 89-96%) and 91%
(95% CI 84-95%), respectively, for children with dilated CM, and 92% (95% CI: 76-97%)
at both time points for children with unclassified CM. Embolic phenomena included a
cerebrovascular event in 5 cases and a pulmonary embolus in 1. The risk of death or
transplantation was significantly increased for all study patients with thromboembolism
(hazard ratio 4.2; 95%CI: 1.6-11.2) as well as for those with dilated CM alone (hazard
ratio 4.6; 95% CI: 1.45-14.6).
Conclusions: Thromboembolism occurs in up to 9% of children with CM within one year
of diagnosis and is related to early CHF and CM type. Thromboembolic complications
occur early and are associated with an increased risk of death or transplantation.
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Lung From Heart Disease in Infants With Respiratory 
Distress
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Background: Respiratory distress (RD) is a common symptom in infants. RD is usually
caused by lung disease, but can also be a result heart disease. It is often difficult do
determine the cause of RD. N-terminal pro-B-type natriuretic peptide (N-BNP) is co-
secreted along with BNP from cardiac myocytes. Like BNP, N-BNP is a marker for car-
diac volume and pressure overload.
Aim: To determine whether N-BNP levels can differentiate between lung disease and
heart disease in infant with RD.
Methods: Infants (age 1-36m) who presented at Hadassah University Hospital with RD
underwent physical examination, chest X-ray, arterial blood gases and echocardiogram.
Control N-BNP values were obtained from age-matched babies with no acute illness and
no history or signs for heart or lung disease. Plasma N-BNP levels were measured by
Electrochemiluminescence immunoassay (Roche, Germany).
Results: There were 18 infants with lung disease (laryngitis, pneumonia and RSV bron-
chiolitis), 19 infants with heart disease (myocarditis, dilated cardiomyopathy, atrio-ventric-
ular canal, hypertrophic cardiomyopathy and ventricular septal defect) and 16 healthy
infants. Infants with respiratory distress due to heart disease had significantly higher
plasma N-BNP than infants with respiratory distress due to lung disease or control
(table).
* p<0.001 vs lung and vs control; # p<0.05 vs control.
Conclusions: Plasma N-BNP can differentiate infants with RD due to heart disease form
infant with RD due to lung disease.
1152-201 Brain Natriuretic Peptide Correlates With Myocardial 
Performance Index in Congenital Heart Disease Patients
Alice A. Perlowski, John S. Child, Robert S. Ross, Pamela D. Miner, David Geffen School 
of Medicine-UCLA Medical Center, Los Angeles, CA
Background: The myocardial performance index (MPI) is an echocardiographic Dop-
pler-derived measure of ventricular function that has been previously validated in con-
genital heart disease(CHD) patients. It may be preferred over conventional non-invasive
measures of ventricular function in patients with complex anatomy, since it is neither
dependent on geometric shape nor heart rate. Although Brain Natriuretic Peptide (BNP)
is well described as a predictor of systolic and diastolic dysfunction in anatomically cor-
rect hearts, it is unclear how it relates to MPI in those with CHD.
Methods: We prospectively evaluated 54 adult patients with a broad range of both cyan-
otic and noncyanotic heart disease. Included were both surgically repaired and unre-
paired pts. Levels of BNP were measured in all subjects using standardized assays.
Doppler echocardiography was performed on the study subjects within six months of the
BNP assay. No subject had a change in functional clinical status during this interval.
Echo images were evaluated by an experienced observer blinded to BNP results and
clinical status. The MPI was calculated as the interval from AV valve closure to opening
minus ventricular ejection time, divided by ventricular ejection time. EF was calculated
with standard methodology by the same observer.
Results: Of a total of 54 patients with measurable left ventricular (LV) or univentricular
(UV) EFs, 34 had adequate data to calculate LV or UV MPIs. Of 30 pts with measurable
right ventricular (RV) EFs, 23 had adequate data to calculate RV MPIs. BNP was found to
be significantly correlated with LV/UV MPI (r= 0.461 with p= 0.006)and RV MPI (r= 0.748
with p < 0.0001) while LV/UV EF and RV EF had no significant correlation with BNP (r= -
0.189, p= 0.172; r= -0.066, p= 0.729, respectively) using a Pearson’s correlation coeffi-
cient test.
Conclusion: In patients with CHD, BNP correlates significantly with MPI but not with left,
right, or univentricular EF. This appears to be particularly true in the case of geometrically
Group Number Age-months
mean(±sd)
Respiratory rate
mean(±sd)
O2 saturation 
mean(±sd)
N-BNP (pg/ml) 
median
Control 16 14.3(5.4) 36(7.8) 97(1.4) 164
Lung 18 9.2(5.9) 62(16.1)# 89.4(3.7)# 311
Heart 19 11.9(12.3) 68(15.7)# 88.6(4.7)# 15403*
